Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents

The evolution of robotic applications for intracardiac and endovascular procedures

George W. Vetrovec, MD

Cover Story

Adults with congenital heart disease present challenges, rewards for cardiologists

FDA News

FDA panel: Randomized controlled trials should not be required for polypill approval

FDA panel votes against approval of combination drug for BP reduction


A tribute to Peter O. Kwiterovich Jr., MD

NASA to study astronauts’ CV health

In the Journals

HF care varies in low- and middle-income countries

Pacemakers more common among patients with cognitive impairment

Thiazide-induced metabolic adverse events common in older adults

Minor infections may increase children's risk for stroke

Incidence of sick sinus syndrome projected to double within 50 years

Hypertension self-management program linked to lower BP at 12 months

Consensus statement outlines imaging strategies for cardiac dysfunction after cancer therapy

Clopidogrel response impaired among patients with diabetes, CAD

CRT, ICD devices reduced mortality regardless of race, ethnicity

AHA releases policy statement on e-cigarettes

Meeting News Coverage

POPE-2: Colchicine failed to reduce postoperative pericardial effusion

ODYSSEY LONG TERM hints at reduction in CV events with alirocumab

ATLANTIC: Pre-hospital ticagrelor did not benefit reperfusion but lowered stent thrombosis in STEMI

PARADIGM-HF: New drug superior to ACE inhibition

SOLID-TIMI 52: Darapladib after ACS did not lower risk for subsequent events

ANTHEM-HF: Vagus nerve stimulation improved cardiac function in patients with HF

X-VeRT: Rivaroxaban safe, effective in AF patients undergoing cardioversion

TASTE: Thrombus aspiration before PCI failed to reduce mortality at 1 year

STAR-AF 2: Pulmonary vein isolation alone achieved successful outcomes

STICS: Statin therapy did not reduce complications after cardiac surgery

Digoxin raised risk for death in ROCKET AF subanalysis

IBIS-4: High-dose rosuvastatin reduced coronary atherosclerosis in STEMI patients

CONFIRM-HF: Iron supplementation improved HF outcomes

FAME II: FFR-guided PCI improves 2-year outcomes in stable CAD

COPPS-2: Perioperative colchicine reduced incidence of postpericardiotomy syndrome

NECTAR-HF: Vagus nerve stimulation failed to improve cardiac function

BIOSCIENCE: Biodegradable polymer DES noninferior to durable polymer DES in 1-year TLF

Trial Scorecards

Trial Scorecard: TASTE

Trial Scorecard: FOCUS

Trial Scorecard: STICS

Trial Scorecard: SIGNIFY

Trial Scorecard: CONFIRM-HF

Trial Scorecard: INVEST

Trial Scorecard: TASMIN-SR

Trial Scorecard: MORE-CRT